Analyst Ratings for Onyx Pharmaceuticals (ONXX)

Overall Rating: BUY Rating Trend: = Avg. $ Target: $85.06 (-0.6%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
2/8/2013	JMP Securities	New Coverage	Market Outperform (N/A)	100.00 (N/A)	76.11	85.54	12.39%	Details
12/19/2012	UBS	New Coverage	Buy (N/A)	97.00 (N/A)	80.83	85.54	5.83%	Details
12/7/2012	Dawson James	New Coverage	Market Outperform (N/A)	91.00 (N/A)	76.70	85.54	11.53%	Details
10/11/2012	Canaccord Genuity	New Coverage	Buy (N/A)	105.00 (N/A)	86.50	85.54	-1.11%	Details
9/27/2012	Brean Capital » Updated 5/20/2013	New Coverage	Buy (N/A)	115.00 (105.00)	82.52	85.54	3.66%	Details
7/23/2012	Bernstein	Downgrade	Market Perform (Outperform)	N/A (N/A)	76.38	85.54	11.99%	Details
7/23/2012	Jefferies » Updated 6/19/2013	Upgrade	Buy (Hold)	104.00 (N/A)	76.38	85.54	11.99%	Details
7/20/2012	Barclays	Upgrade	Overweight (Equalweight)	85.00 (N/A)	68.40	85.54	25.06%	Details
7/20/2012	Leerink Swann	Upgrade	Outperform (Market Perform)	N/A (N/A)	68.40	85.54	25.06%	Details
6/22/2012	Morgan Stanley	Upgrade	Equalweight (Underweight)	N/A (N/A)	63.78	85.54	34.12%	Details
6/21/2012	Cowen	Upgrade	Outperform (Neutral)	N/A (N/A)	61.38	85.54	39.36%	Details
6/21/2012	Baird » Updated 1/4/2013	Upgrade	Outperform (Neutral)	99.00 (99.00)	61.38	85.54	39.36%	Details
6/21/2012	Deutsche Bank » Updated 8/16/2012	New Coverage	Buy (N/A)	105.00 (N/A)	61.38	85.54	39.36%	Details
6/8/2012	BofA/Merrill Lynch	Upgrade	Buy (Neutral)	57.00 (47.00)	43.60	85.54	96.19%	Details
5/3/2012	Goldman Sachs » Updated 6/21/2012	Downgrade	Buy (N/A)	63.00 (52.00)	45.00	85.54	90.09%	Details

Like ONXX Ratings? Also take a look at LGND, GSK, PURE, CELG